Syndrome News and Research

RSS

A fast and powerful method for the production of SARS-CoV-2 virus-like particles in insect cells

Researchers presented the direct plasmid transfection method for SARS-CoV-2 virus-like particle production in insect cells and applied the VLPs to evaluate the efficacy of monoclonal antibodies and vaccinated donor sera.

26 Sep 2022

Study of 9 million Swedes shows rapidly declining effectiveness of COVID vaccines against Omicron

The findings of a new Swedish study posted to the Preprints with The Lancet* server found that two COVID-19 vaccine doses provided effective long-term protection against infection before Omicron, but less protection against Omicron infection (dropping to 43% by week four and no protection by week 14).

25 Sep 2022

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

In a recent study posted to the medRxiv* preprint server, researchers in the United States described the safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), tested in PREVENT-19 — a phase 3, randomized, placebo-controlled, observer-blinded trial among 12- to 17-year-old adolescents in the United States (U.S).

25 Sep 2022

Cancer survival rate rises in the US

In a recent article by the American Association for Cancer Research (AACR), the researchers highlighted basic, translational, and clinical cancer research and cancer-related population sciences in the 12th edition of its annual Cancer Progress Report.

25 Sep 2022

How smallpox and monkeypox viruses affect the nervous system

A recent study provides an overview of existing literature on the complications of infection with both smallpox and monkeypox virus.

25 Sep 2022

Novel PTP1B inhibitor drug candidate can prevent lethal lung inflammation in mice

Neutrophils, the most abundant type of white blood cell, are the body's first line of defense against infection. Foreign pathogens can stress the body and activate neutrophils.

23 Sep 2022

Study reveals a testable hypothesis to explain the initiation of autoimmunity in T1D patients

Type 1 diabetes (T1D) is an autoimmune disease in which the pancreas makes little or no insulin. The details on the events that occur during autoimmune destruction of the pancreatic beta-cells have been studied extensively yet the mystery of what causes autoimmunity is unknown.

23 Sep 2022

Scientists identify the mechanism responsible for exceptional auditory abilities in Williams-Beuren syndrome

Williams-Beuren syndrome (WBS) is a rare disorder that causes neurocognitive and developmental deficits. However, musical and auditory abilities are preserved or even enhanced in WBS patients.

23 Sep 2022

Study describes the dynamics of immune responses to triple COVID-19 vaccination

The effectiveness of the three-dose COVID-19 vaccination against SARS-CoV-2 and its variants has been described in detail in a recent study.

23 Sep 2022

Shattered dreams and bills in the millions: Losing a baby in America

The day after his 8-month-old baby died, Kingsley Raspe opened the mail and found he had been sent to collections for her care.

23 Sep 2022

Dietary sugar may disrupt gut microbiota and induce metabolic complications

A new study demonstrates that dietary sugar increases the risk of metabolic syndrome by disrupting gut microbiota and suppressing protective T helper 17 (Th17) cells.

22 Sep 2022

Study using circulating spike protein and macrophage dysregulation liquid biomarkers reveals heterogeneity in PASC

In a new study, researchers designed a liquid biomarker panel consisting of macrophage and monocyte-related soluble factors and circulating spike proteins to understand profiles of immune dysregulation in patients with post-acute sequelae of COVID-19.

22 Sep 2022

What role does cross-reactive immunity play in the spread of a novel SARS-CoV-2 variant?

In a new study, researchers used mathematical modeling to examine the effect of cross-reactive immunity from previous infections on an emerging SARS-CoV-2 variant, and explored the probability of the novel variant causing widespread infection or fading out.

22 Sep 2022

Syndrome News and Research

A fast and powerful method for the production of SARS-CoV-2 virus-like particles in insect cells

Study of 9 million Swedes shows rapidly declining effectiveness of COVID vaccines against Omicron

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

Cancer survival rate rises in the US

How smallpox and monkeypox viruses affect the nervous system

Novel PTP1B inhibitor drug candidate can prevent lethal lung inflammation in mice

Study reveals a testable hypothesis to explain the initiation of autoimmunity in T1D patients

Scientists identify the mechanism responsible for exceptional auditory abilities in Williams-Beuren syndrome

Study describes the dynamics of immune responses to triple COVID-19 vaccination

Shattered dreams and bills in the millions: Losing a baby in America

Dietary sugar may disrupt gut microbiota and induce metabolic complications

Study using circulating spike protein and macrophage dysregulation liquid biomarkers reveals heterogeneity in PASC

What role does cross-reactive immunity play in the spread of a novel SARS-CoV-2 variant?

Does BA.2 breakthrough infection shift cross-neutralization activity towards the BA.4 and BA.5 Omicron sublineages?

Can a commercial breath analysis test detect SARS-CoV-2?

What is the efficacy of the BCG vaccine against SARS-CoV-2 infection?

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

Most people infected with SARS-CoV2 recover within 12 months, study finds

Deep mutational scanning for SARS-CoV-2 Omicron BA.1 and BA.2 subvariants

How frequent was SARS-CoV-2 and malaria co-infection during the first wave of the pandemic?

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News